Lifecore Biomedical, Inc. \De\ (LFCR) Shares Outstanding (Weighted Average) (2016 - 2025)
Lifecore Biomedical, Inc. \De\ has reported Shares Outstanding (Weighted Average) over the past 16 years, most recently at $34.8 million for Q2 2025.
- Quarterly results put Shares Outstanding (Weighted Average) at $34.8 million for Q2 2025, up 14.26% from a year ago — trailing twelve months through May 2025 was $34.8 million (up 14.26% YoY), and the annual figure for FY2025 was $34.8 million, up 14.26%.
- Shares Outstanding (Weighted Average) for Q2 2025 was $34.8 million at Lifecore Biomedical, Inc. \De\, down from $37.0 million in the prior quarter.
- Over the last five years, Shares Outstanding (Weighted Average) for LFCR hit a ceiling of $37.0 million in Q1 2025 and a floor of $29.3 million in Q1 2021.
- Median Shares Outstanding (Weighted Average) over the past 5 years was $29.9 million (2023), compared with a mean of $30.8 million.
- Biggest five-year swings in Shares Outstanding (Weighted Average): increased 0.38% in 2021 and later rose 21.58% in 2025.
- Lifecore Biomedical, Inc. \De\'s Shares Outstanding (Weighted Average) stood at $29.4 million in 2021, then increased by 0.63% to $29.6 million in 2022, then increased by 2.78% to $30.5 million in 2023, then grew by 12.81% to $34.4 million in 2024, then increased by 1.33% to $34.8 million in 2025.
- The last three reported values for Shares Outstanding (Weighted Average) were $34.8 million (Q2 2025), $37.0 million (Q1 2025), and $34.4 million (Q4 2024) per Business Quant data.